(PDF) Effect of Aclidinium Bromide on Cough and Sputum

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

BMJ Open Respiratory Research - United Kingdom

doi 10.1136/bmjresp-2016-000148

Full Text

Open PDF

Abstract

Available in full text

Date

December 1, 2016

Authors

Publisher

BMJ

Related search

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD

ClinicoEconomics and Outcomes Research

English

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

English

Overall and Cardiovascular Safety of Aclidinium Bromide in Patients With COPD: A Pooled Analysis of Six Phase III, Placebo-Controlled, Randomized Studies

Chronic Obstructive Pulmonary Diseases

Pulmonary

Respiratory Medicine

2016

English

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

International Journal of Medicine and Pharmacy

2014

English

Risk Factors for Cardiovascular Disease in Patients With COPD: Mild-To-Moderate COPD Versus Severe-To-Very Severe COPD

Jornal Brasileiro de Pneumologia

Pulmonary

Respiratory Medicine

2016

English

Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )

British Journal of Dermatology

Dermatology

Medicine

2019

English

Chronic Cough and Sputum Production: A Clinical COPD Phenotype?: Table 1–

European Respiratory Journal

English

Effect of Ospemifene on Moderate or Severe Symptoms of Vulvar and Vaginal Atrophy

English

Heterogeneity in the Respiratory Symptoms of Patients With Mild-To-Moderate COPD

International Journal of COPD

English

Amanote Research

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

BMJ Open Respiratory Research - United Kingdom

doi 10.1136/bmjresp-2016-000148

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

Overall and Cardiovascular Safety of Aclidinium Bromide in Patients With COPD: A Pooled Analysis of Six Phase III, Placebo-Controlled, Randomized Studies

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

Risk Factors for Cardiovascular Disease in Patients With COPD: Mild-To-Moderate COPD Versus Severe-To-Very Severe COPD

Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )

Chronic Cough and Sputum Production: A Clinical COPD Phenotype?: Table 1–

Effect of Ospemifene on Moderate or Severe Symptoms of Vulvar and Vaginal Atrophy

Heterogeneity in the Respiratory Symptoms of Patients With Mild-To-Moderate COPD

Amanote Research

Effect of Aclidinium Bromide on Cough and Sputum Symptoms in Moderate-To-Severe COPD in Three Phase III Trials

BMJ Open Respiratory Research - United Kingdom

doi 10.1136/bmjresp-2016-000148

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Cost Versus Utility of Aclidinium Bromide 400 &Mu;g Plus Formoterol Fumarate Dihydrate 12 &Mu;g Compared to Aclidinium Bromide 400 &Mu;g Alone in the Management of Moderate-To-Severe COPD

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

Overall and Cardiovascular Safety of Aclidinium Bromide in Patients With COPD: A Pooled Analysis of Six Phase III, Placebo-Controlled, Randomized Studies

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

Risk Factors for Cardiovascular Disease in Patients With COPD: Mild-To-Moderate COPD Versus Severe-To-Very Severe COPD

Laboratory Safety of Dupilumab in Moderate‐to‐severe Atopic Dermatitis: Results From Three Phase III Trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )

Chronic Cough and Sputum Production: A Clinical COPD Phenotype?: Table 1–

Effect of Ospemifene on Moderate or Severe Symptoms of Vulvar and Vaginal Atrophy

Heterogeneity in the Respiratory Symptoms of Patients With Mild-To-Moderate COPD

Cost Versus Utility of Aclidinium Bromide 400 Μg Plus Formoterol Fumarate Dihydrate 12 Μg Compared to Aclidinium Bromide 400 Μg Alone in the Management of Moderate-To-Severe COPD